Mireia Sueca-Comes
The role of mesenchymal cells in cholangiocarcinoma
Sueca-Comes, Mireia; Rusu, Elena Cristina; Ashworth, Jennifer C.; Collier, Pamela; Probert, Catherine; Ritchie, Alison; Meakin, Marian; Mongan, Nigel P.; Egbuniwe, Isioma U.; Andersen, Jesper Bøje; Bates, David O.; Grabowska, Anna M.
Authors
Elena Cristina Rusu
Miss JENNIFER ASHWORTH JENNIFER.ASHWORTH@NOTTINGHAM.AC.UK
ANNE MCLAREN RESEARCH FELLOW
Pamela Collier
Catherine Probert
Alison Ritchie
Marian Meakin
Professor Nigel Mongan nigel.mongan@nottingham.ac.uk
ASSOCIATE PRO-VICE CHANCELLORGLOBAL ENGAGEMENT
Isioma U. Egbuniwe
Jesper Bøje Andersen
Professor DAVID BATES David.Bates@nottingham.ac.uk
PROFESSOR OF ONCOLOGY
Anna M. Grabowska
Abstract
The tumour microenvironment (TME) significantly influences tumour formation and progression through dynamic interactions. Cholangiocarcinoma (CCA), a highly desmoplastic tumour, lacks early diagnostic biomarkers and has limited effective treatments owing to incomplete understanding of its molecular pathogenesis. Investigating the role of the TME in CCA progression could lead to better therapies. RNA sequencing was performed on seven CCA patient-derived xenografts (PDXs) and their corresponding patient samples. Differential expression analysis was conducted, and Qiagen Ingenuity Pathway Analysis was used to predict dysregulated pathways and upstream regulators. PDX- and cell line-derived spheroids, with and without immortalised mesenchymal stem cells, were grown and analysed for morphology, growth and viability. Histological analysis confirmed biliary phenotypes. RNA sequencing indicated upregulation of extracellular matrix-receptor interaction and PI3K-AKT pathways in the presence of mesenchymal cells, with several genes linked to poor survival. Mesenchymal cells restored the activity of inhibited cancer-associated kinases. Thus, adding mesenchymal cells to CCA spheroid models restored key paracrine signalling pathways lost in PDXs, enhancing tumour growth and viability. These findings highlight the importance of including stromal components in cancer models to improve pre-clinical studies.
Citation
Sueca-Comes, M., Rusu, E. C., Ashworth, J. C., Collier, P., Probert, C., Ritchie, A., Meakin, M., Mongan, N. P., Egbuniwe, I. U., Andersen, J. B., Bates, D. O., & Grabowska, A. M. (2024). The role of mesenchymal cells in cholangiocarcinoma. Disease Models and Mechanisms, 17(12), Article dmm050716. https://doi.org/10.1242/dmm.050716
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 17, 2024 |
Online Publication Date | Nov 4, 2024 |
Publication Date | 2024-12 |
Deposit Date | Nov 15, 2024 |
Publicly Available Date | Nov 19, 2024 |
Journal | Disease Models and Mechanisms |
Print ISSN | 1754-8403 |
Electronic ISSN | 1754-8411 |
Publisher | Company of Biologists |
Peer Reviewed | Peer Reviewed |
Volume | 17 |
Issue | 12 |
Article Number | dmm050716 |
DOI | https://doi.org/10.1242/dmm.050716 |
Keywords | Cholangiocarcinoma, PDX models, Mesenchymal stem cells, Signalling pathways, Tumour microenvironment |
Public URL | https://nottingham-repository.worktribe.com/output/41678898 |
Publisher URL | https://journals.biologists.com/dmm/article/doi/10.1242/dmm.050716/362583/The-role-of-mesenchymal-cells-in |
Files
dmm050716
(12.2 Mb)
PDF
Licence
https://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search